Acciones PharmaCyte Biotech, Inc. Other OTC
Acciones
PMCB
US71715X1046
Farmacéuticos
Ventas 2022 | - | Ventas 2023 | - | Capitalización | 50,93 M 46,93 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -4 M -3,69 M | Resultado Neto 2023 | -4 M -3,69 M | VE / Ventas 2022 | - |
Posición de caja neta 2022 | 85,4 M 78,69 M | Posición de caja neta 2023 | 68,04 M 62,69 M | VE / Ventas 2023 | - |
P/E ratio 2022 |
-8,53
x | P/E ratio 2023 |
-13,2
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 35,95 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15/08/22 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01/01/15 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 10/08/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 14/11/22 |
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15/08/22 |
Wayne Walker
BRD | Director/Board Member | 65 | 28/12/22 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+37,55 % | 705 mil M | |
+32,40 % | 583 mil M | |
-2,94 % | 364 mil M | |
+20,58 % | 332 mil M | |
+5,90 % | 291 mil M | |
+16,21 % | 238 mil M | |
-3,52 % | 210 mil M | |
+10,50 % | 209 mil M | |
+9,46 % | 169 mil M |